首页> 外文OA文献 >Effects of a luteinizing hormone-releasing hormone agonist on cognitive, sexual, and hormonal functions in patients with prostate cancer: relationship with testicular and adrenal androgen levels

【2h】

Effects of a luteinizing hormone-releasing hormone agonist on cognitive, sexual, and hormonal functions in patients with prostate cancer: relationship with testicular and adrenal androgen levels

机译：黄体生成素释放激素激动剂对前列腺癌患者认知，性和激素功能的影响：与睾丸和肾上腺雄激素水平的关系

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Kohei Okamoto; Yositaka Sekine; Masashi Nomura; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Effects of a luteinizing hormone-releasing hormone agonist on cognitive, sexual, and hormonal functions in patients with prostate cancer: relationship with testicular and adrenal androgen levels [J] . Kohei Okamoto, Yositaka Sekine, Masashi Nomura, Basic and Clinical Andrology . 2015,第1期

机译：黄体生成素释放激素激动剂对前列腺癌患者认知，性和激素功能的影响：与睾丸和肾上腺雄激素水平的关系
2. Luteinizing Hormone (LH)-Releasing Hormone Agonist Reduces Serum Adrenal Androgen Levels in Prostate Cancer Patients: Implications for the Effect of LH on the Adrenal Glands. [J] . Masahiro Nishii, Masashi Nomura, Yoshitaka Sekine, Journal of Andrology . 2012,第6期

机译：黄体生成激素（LH）-释放激素激动剂可降低前列腺癌患者的血清肾上腺雄激素水平：对LH对肾上腺的影响。
3. Time course of serum testosterone and luteinizing hormone levels after cessation of long-term luteinizing hormone-releasing hormone agonist treatment in patients with prostate cancer. [J] . Kaku H, Saika T, Tsushima T, The Prostate . 2006,第4期

机译：前列腺癌患者长期停止黄体生成激素释放激素激动剂治疗后血清睾丸激素和黄体生成激素水平的时程。
4. Serum levels of sex hormones before and after androgen deprivation therapy in Japanese prostate cancer patients [C] . A. Komiya, K. Ichimatsu, A. Morii, International Congress of Andrology . 2009

机译：日本前列腺癌患者中雄激素剥夺治疗前后的性激素血清水平
5. Changes in bone mineral density in men with prostate cancer during treatment with luteinizing hormone-releasing hormone (LHRH) agonist monotherapy. [D] . Conde, Francisco Alcasid, II. 2003

机译：黄体激素释放激素（LHRH）激动剂单药治疗期间前列腺癌男性的骨矿物质密度变化。
6. Effects of a luteinizing hormone-releasing hormone agonist on cognitive sexual and hormonal functions in patients with prostate cancer: relationship with testicular and adrenal androgen levels [O] . Kohei Okamoto, Yositaka Sekine, Masashi Nomura, 2015

机译：黄体生成素释放激素激动剂对前列腺癌患者认知性和激素功能的影响：与睾丸和肾上腺雄激素水平的关系
7. Prior administration of a non-steroidal anti-androgen failed to prevent the flare-up caused by a luteinizing hormone-releasing hormone agonist in a patient with metastatic prostate cancer [O] . Sho Uehara, Takeshi Yuasa, Yasuhisa Fujii, 2015

机译：先前给予非甾体类抗雄激素药物未能预防由黄体化激素释放激素激动剂引起的转移性前列腺癌患者发作

Effects of a luteinizing hormone-releasing hormone agonist on cognitive, sexual, and hormonal functions in patients with prostate cancer: relationship with testicular and adrenal androgen levels

著录项

相似文献

相关主题

期刊订阅